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INTRODUCTION
Genetics has a great influence over components of athletic perfor-
mance such as strength, power, endurance, muscle fibre size and 
composition, flexibility, neuromuscular coordination, temperament 
and other phenotypes. Accordingly, athlete status is a heritable trait: 
around 66% of the variance in athlete status is explained by additive 
genetic factors. The remaining variance is due to non-shared envi-
ronmental factors [10]. Despite the relatively high heritability of 
athlete status, the search for genetic variants contributing to predis-
position to success in certain types of sport has been a challenging 
task. 
Sports genomics is a relatively new scientific discipline focusing 
on the organization and functioning of the genome of elite athletes. 
The era of sports genomics began in the early 2000s after decipher-
ing the human DNA structure and discovery of the first genetic mark-
ers associated with athletic performance (e.g. ACE, ACTN3 and 
AMPD1 gene variations). With genotyping becoming widely available, 
a large number of genetic case-control studies evaluating candidate 
gene variants have been published with largely unconfirmed asso-
ciations with elite athlete status.
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A recent review provided evidence that at least 79 genetic mark-
ers (located within 40 autosomal genes, mitochondrial DNA and 
Y-chromosome) are linked to elite athlete status (59 endurance-re-
lated and 20 power/strength-related genetic markers) [2]. Although 
most of the case-control and association studies have not yet been 
replicated in independent samples, 20 genetic markers have shown 
positive associations with athlete status in at least two studies   
(14 endurance-related genetic markers: ACE I, ACTN3 577X, ADRB2 
16Arg, AMPD1 Gln12, BDKRB2 –9, COL5A1 rs12722 T, GABPB1 
rs7181866 G and rs12594956 A, HFE 63Asp, KCNJ11 Glu23, 
PPARA rs4253778 G, PPARD rs2016520 C, PPARGC1A Gly482, 
UCP3 rs1800849 T; and 6 power/strength-related genetic markers: 
ACE D, ACTN3 Arg577, AMPD1 Gln12, HIF1A 582Ser, NOS3 
rs2070744 T, PPARA rs4253778 C). 
The aim of the study was to investigate the association of   
ACE I/D, HIF1A Pro582Ser, NOS3 -786 T/C, PPARA intron 7 G/C, 
PPARG Pro12Ala and PPARGC1B Ala203Pro gene polymorphisms 
with athlete status in Ukrainians. Of the six gene variants, the HIF1A, 
PPARA, PPARG and PPARGC1B genes code for transcription factors 
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and coactivators (primarily involved in glucose, insulin and lipid 
metabolism, mitochondrial biogenesis, thermogenesis, and regulation 
of muscle fibre type composition), while ACE and NOS3 code for 
enzymes involved in the regulation of vascular functions (Table 1).
MATERIALS AND METHODS 
Study participants. In total, 210 Ukrainian athletes (145 males and 
65 females; age 22.1±2.5 years; 65 elite athletes, 127 sub-elite 
athletes and 18 non-elite athletes) were recruited from the endurance-
oriented (n=100; cross-country skiers, rowers) and power-oriented 
(n=110; short distance runners, short distance swimmers, jumpers, 
throwers) sports. Controls were 326 healthy unrelated Ukrainians 
(187 males and 139 females; age 14-54 years) without any com-
petitive sport experience. The athletes and control groups were all 
Caucasians. 
The Regional Ethics Committee (Kiev, Ukraine) approved the study 
and written informed consent was obtained from each participant. 
All experiments were performed in accordance with the ethical stan-
dards of the Helsinki Declaration.
Genotyping 
Molecular genetic analysis was performed with DNA samples obtained 
from epithelial mouth cells using a Diatom
TM DNA Prep kit according 
to the manufacturer’s instructions (Biokom, Russia). Genotyping for 
6 gene polymorphisms was performed by PCR and restriction enzyme 
digestion as reported previously [6]. All genotyping analyses were 
conducted blind to subject identity. 
Calculation of total genotype score
To quantify the combined influence of polymorphisms associated 
with power or endurance phenotypes, an algorithm [16,24] was 
used to incorporate all favourable genotype scores for any given in-
dividual in a simple additive model. The total score was then trans-
formed mathematically to lie within the range 0–100 and labelled 
the ‘total genotype score’ (TGS). A TGS of 100 represents a ‘perfect’ 
polygenic profile for power/endurance and a TGS of 0 represents   
the ‘worst’ possible profile for power/endurance. 
Statistical analysis 
Statistical analyses were conducted using SPSS ver. 17.0 software 
package. Genotype distribution and allele frequencies between each 
of the two groups of athletes (endurance-oriented and power-orient-
ed) and controls were compared using χ
2 tests. P values < 0.05 
were considered statistically significant.
RESULTS 
Genotype distributions of 6 gene polymorphisms in the control group 
and amongst all athletes were in Hardy-Weinberg equilibrium. There 
were no significant differences in ACE, PPARA and PPARGC1B 
genotype and allele frequencies between different groups of athletes 
and controls (Table 2). Power-oriented athletes exhibited an increased 
frequency of the HIF1A Ser (16.1 vs. 9.4%, P = 0.034) and 
NOS3 T alleles (78.3 vs. 66.2%, P = 0.0019) in comparison with 
controls (Table 2). Compared with the HIF1A Pro/Pro carriers, 
the odds ratio (OR) of being a power-oriented athlete in Ser allele 
carriers (Pro/Ser+Ser/Ser) was 2.042 (95% confidence interval   
(CI): 1.078-3.871, P = 0.0315). Similarly, the OR of being a pow-
er-oriented athlete in the NOS3 TT genotype carriers was 2.262 
(95% CI: 1.396-3.664; P = 0.008).
Additionally, we found that the frequency of the PPARG Ala allele 
was significantly higher in power-oriented athletes compared with the 
endurance-oriented athletes (24.7 vs. 13.5%; P = 0.0076). Further-
more, the distribution of PPARG genotypes was significantly different 
between endurance-oriented athletes and controls (P = 0.012). 
Gene Full name Functions, associated phenotypes and interactions
ACE
Angiotensin I converting 
enzyme
Regulates circulatory homeostasis through the synthesis of vasoconstrictor angiotensin II and the 
degradation of vasodilator kinins. 
HIF1A
Hypoxia inducible factor 1, 
α subunit
Regulates the transcription of numerous genes in response to hypoxic stimuli. Genes responsive 
to HIF1 are involved in the processes of erythropoiesis, angiogenesis, and metabolism and include 
those encoding erythropoietin, VEGF, PPARα and glycolytic enzymes.
NOS3 Nitric oxide synthase 3
Generates nitric oxide (NO) in blood vessels and is involved with regulating vascular function. 
NO is an important cellular signalling molecule involved in many physiological and pathological 
processes. It is a powerful vasodilator with a short half-life of a few seconds in the blood. 
PPARA
Peroxisome proliferator-
activated receptor α
Regulates liver, heart and skeletal muscle lipid metabolism, glucose homeostasis, mitochondrial 
biogenesis, cardiac hypertrophy, expression of UCP2 and UCP3 genes.
PPARG
Peroxisome proliferator-
activated receptor γ
Plays a critical physiological role as a central transcriptional regulator of adipogenic and lipogenic 
programmes, insulin sensitivity and glucose homeostasis.
PPARGC1B
Peroxisome proliferator-
activated receptor γ 
coactivator 1 β
Regulates fatty acid oxidation, mitochondrial biogenesis, formation of muscle fibres; co-activates 
PPARα and PPARγ.
TABLE 1.  CANDIDATE  GENES  FOR  ATHLETE  STATUS;  THEIR  FULL  NAMES,  FUNCTIONS  OF  GENE  PRODUCTS,  ASSOCIATED 
PHENOTYPES AND INTERACTIONS
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TABLE 2. GENOTYPE DISTRIBUTIONS AND MINOR ALLELE FREQUENCIES OF CANDIDATE GENES IN UKRAINIAN ATHLETES AND 
CONTROLS
Next, we determined the TGS in athletes and controls. The mean 
TGS was significantly higher in power-oriented athletes (39.1 ± 2.3 
vs. 32.6 ± 1.5; P = 0.0142) than in controls.
DISCUSSION 
The present study demonstrates that the HIF1A Pro582Ser, NOS3 
–786 T/C and PPARG Pro12Ala polymorphisms are associated with 
elite athlete status in Ukrainians. We found that the HIF1A Ser, 
NOS3 T and PPARG Ala alleles were over-represented in power-
oriented athletes compared with controls or endurance-oriented 
athletes. We also identified a polygenic profile (by the use of combi-
nation of the HIF1A, NOS3 and PPARG polymorphisms) of power-
oriented athletes that allowed us, at least partly, to distinguish 
power-oriented athletes from controls. These polymorphisms have 
already been associated with power athlete status and/or power-
related phenotypes in other studies [3,4,9,13,14,15,20], so our 
data replicate those previous findings. 
Of those genes listed, HIF1A codes for hypoxia-inducible factor 
1 (HIF-1A), which controls the expression of several genes impli-
cated in various cellular functions including glucose metabolism 
(glucose transporters and glycolytic enzymes). A missense polymor-
phism, Pro582Ser, is present in exon 12 (C/T at bp 85; rs11549465). 
The rare T allele is predicted to result in a proline to serine change 
in the amino acid sequence of the protein. This substitution in-
creases HIF-1A protein stability and transcriptional activity [21], and 
therefore may improve glucose metabolism and lower the risk of type 
2 diabetes [19]. The frequency of the HIF1A Ser allele was signifi-
cantly higher in Russian weightlifters and wrestlers than in controls 
and increased with their levels of achievement [3,14]. These results 
were replicated in a cohort of Polish power-orientated athletes [9], 
but not in Israeli sprinters [13]. Furthermore, the Ser allele was 
significantly associated with an increased proportion of fast-twitch 
muscle fibres in m. vastus lateralis of all-round speed skaters [3].
Nitric oxide (NO) is involved in human skeletal muscle uptake 
during exercise [18] and modulation of oxygen consumption in skel-
etal muscles [23]. Dietary nitrate supplementation enhances muscle 
contractile efficiency during knee-extensor exercise and tolerance to 
high-intensity exercise in humans [7,8]. We have previously shown 
Gene Polymorphism Genotype / allele Endurance-oriented  
athletes
Power-oriented  
athletes Controls
ACE Alu I/D n=84 n=108 n=283
II 26.5 25.9 25.1
ID 48.2 45.4 53.0
DD 25.3 28.7 21.9
MAF (D) 0.494 0.514 0.484
PPARA  intron 7 G/C n=80 n=71 n=85
GG  73.8 73.2 67.1
GC 26.0 23.9 30.6
CC 0 2.8 2.7
MAF (C) 0.130 0.140 0.180
PPARG Pro12Ala n=100 n=87 n=318
Pro/Pro 77.0 55.2 64.2
Pro/Ala 19.0 40.2 34.0
Ala/Ala 4.0 4.6 1.8
MAF (Ala) 0.135
§ 0.247 0.189
PPARGC1B Ala203Pro n=73 n=59 n=81
Ala/Ala 84.4 86.4 88.9
Ala/Pro 13.7 11.9 11.1
Pro/Pro 1.4 1.7 0
MAF (Pro) 0.082 0.07 0.05
HIF1A Pro582Ser n=81 n=59 n=260
Pro/Pro 86.4 69.5 82.3
Pro/Ser 13.6 28.8 16.5
Ser/Ser 0 1.7 1.2
MAF (Ser) 0.07 0.161* 0.094
 NOS3  -786 T/C n=82 n=90 n=321
TT 45.1 63.3 43.3
TC 46.3 30.0 45.8
CC 8.5 6.7 10.9
MAF (C) 0.317
§ 0.217* 0.338
Note: MAF, minor allele frequency. *P<0.05, statistically significant differences between power-oriented athletes and controls. 
§P<0.05, statistically 
significant differences between endurance-oriented athletes and power-oriented athletes.
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that the level of the endothelial nitric oxide synthase gene (NOS3) 
mRNA and NOS3 (NOS3 generates NO in blood vessels) activity in 
isolated platelets is higher in TT genotype carriers of the –786 T/C 
(rs2070744) polymorphism [12]. Therefore, one might anticipate 
that genetic variation in the NOS3 gene could be associated with 
power/sprint performance. Indeed, Gómez-Gallego et al. [15] found 
that the frequency of the NOS3 T allele was significantly higher in 
53 Spanish elite power-oriented athletes (jumpers, throwers, sprint-
ers) compared to 100 non-athletic controls (frequency of the T allele: 
71.0% vs. 56.0%; P = 0.015). These results were confirmed in 
the second study involving Italian power-oriented athletes [20] and 
in the present study.
Peroxisome proliferator-activated receptor γ (PPAR γ; encoded by 
PPARG) plays a critical physiological role as a central transcrip-
tional regulator of adipogenic and lipogenic programmes, insulin 
sensitivity and glucose homeostasis. The Ala variant of the PPARG 
gene Pro12Ala polymorphism (rs1801282 C/G) is associated with 
decreased receptor activity [11], improved insulin sensitivity [11] 
and increased body mass index in humans [5,17]. Carriers of the 
Ala allele show a better glycaemic response to exercise training [1], 
higher rates of skeletal muscle glucose uptake [22] and greater cross-
sectional area of muscle fibres [4]. In a study of Russian power-
oriented athletes (n = 260), a higher frequency (23.8% vs. 15.1%, 
P < 0.0001) of the PPARG 12Ala allele compared to 1,073 controls 
was reported [4]. The present study involving Ukrainian athletes has 
confirmed those findings.
On the other hand, we could not confirm the association between 
the ACE, PPARA and PPARGC1B gene polymorphisms and athletic 
performance, presumably due to the limited number of studied ath-
letes. In addition, our study is limited to 6 common polymorphisms 
which were primarily selected because of previously reported asso-
ciations with various aspects of power performance. There are already 
other genetic variants that have been reported to show associations 
with aspects of power [2,16], and we strongly suspect that many 
additional common polymorphisms, and probably rare mutations as 
well, will be shown to be associated with power performance or   
a power phenotype in due course.
CONCLUSIONS 
In conclusion, we found that the HIF1A Ser, NOS3 T and PPARG 
Ala alleles were associated with power athlete status in Ukrainians. 
Our data also suggest an overall more ‘favourable’ polygenic profile 
in power-oriented athletes compared to controls. The results are in 
agreement with previous studies and suggest an opportunity to use 
the analysis of HIF1A Pro582Ser, NOS3 –786 T/C and PPARG 
Pro12Ala polymorphisms along with other gene variations and stan-
dard phenotypic assessment in sports selection.
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